A 6-month multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and PK/PD of an age and body-weight-adjusted oral Finerone regimen, in addition to an ACEI or ARB, for the treatment of children, 6 months to to <18 years of age, with chronic kidney disease and proteinuria < .